October 25, 2023
Aro Biotherapeutics Announces Start of First in Human Study with ABX1100, a Novel First in Class Centyrin-siRNA Conjugate in Development for Pompe Disease
Media
October 24, 2023
Rampart Bioscience Announces $85M Series A Financing to Develop Novel DNA-Based Medicines with Veteran Team
October 20, 2023
Oncopeptides announces the Nomination Committee
October 19, 2023
BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for Interim report Q3 2023
October 18, 2023
Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal Hyperplasia
October 17, 2023
Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023
October 16, 2023
BONESUPPORT receives “breakthrough device designation” for CERAMENT® V for the indication of bone infection
October 16, 2023
Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti And David Meek To Its Board Of Directors
October 16, 2023
Aprea Unveils Initial Clinical Data on ATRi, ATRN-119, and Pre-Clinical Data on WEE1i, ATRN-1051, at AACR-NCI-EORTC International Conference Supporting Highly Differentiated Synthetic Lethality Portfolio
October 12, 2023
Fusion Pharmaceuticals Announces Presentation Of Preclinical Data Supporting FPI-2068, A Novel Targeted Alpha Therapy For EGFR-CMET Expressing Cancers